Welcome to the High Throughput Genomic Sequencing Facility

HTSF Year End Deadlines

To all HTSF Users:

As we approach the end of the calendar year, there will be a number of UNC holidays and breaks in Illumina services. This will cause the HTSF to have a shortened timeline to complete work before the end of the year. We want to make sure we can accept and complete all work as expected by studies. For this reason, we have the following dates as deadlines for submission of work. These deadlines apply to all sequencing systems in the HTSF including Illumina HiSeq and MiSeq.

We will make every effort to deliver all data by end of the day on 12/20 if work is submitted according to the deadlines listed. But depending on services required, we cannot guarantee data receipt before closure. If we have sample quality or machine issues, which can delay in data delivery, we will let study know what samples will be impacted. As always, we request that studies understand that the first samples received, will be the first samples worked on for completion.

Of course, we will accept all material up until we close. Samples dropped off after deadlines may not be started before the closure. If you have concerns, please contact us prior to your submission / drop off of materials so we can address any issues.

Thank you for understanding the need to adhere to the deadlines.

The HTSF Staff

DEADLINES

10/26 — last day for raw material submission to have standard libraries made/ QAQC/ pooled / sequenced
11/14 — last day for library submission to be QAQC/ pooled/ sequenced
11/26 — last day for study made pools to be QAQC / sequenced
12/20 — last day for data to be delivered
12/21 — last day to have materials to be dropped off (12n deadline)/ work started after the first of the yr
1/2/2019 – HTSF reopens for business

History and Mission

The HTSF was established in 2008 with funds from the University Cancer Research Fund (UCRF) and the Lineberger Comprehensive Cancer Center (LCCC) and is managed by the UNC School of Medicine.

Our primary goal is to apply the tools of high throughput sequencing technology and experience to enrich medicine and basic biological research at The University of North Carolina. High-throughput sequencing is an extremely fast developing technology that is used to extract genetic and genomic data from a broad spectrum of biological materials. This information is not only be used to help identify the causes of complex diseases such as cancer, diabetes and cardiovascular disease and demonstrate the underlying bases for multiple types of infectious diseases.  It can be also used to analyze the complexities of diverse biological systems. Our goal is to support UNC researchers, students, and their collaborators in their work with our state-of-the-art technology to make medical and scientific breakthroughs happen.

We support all commercially available high throughput sequencing platforms and regularly work with researchers to develop and implement novel cutting edge applications with these platforms. We frequently work directly with the developers of new systems as an early access customer to give them useful feedback and to give our researchers the earliest possible access to novel new technologies.